CO4940415A1 - Compuesto quimico - Google Patents

Compuesto quimico

Info

Publication number
CO4940415A1
CO4940415A1 CO98011404A CO98011404A CO4940415A1 CO 4940415 A1 CO4940415 A1 CO 4940415A1 CO 98011404 A CO98011404 A CO 98011404A CO 98011404 A CO98011404 A CO 98011404A CO 4940415 A1 CO4940415 A1 CO 4940415A1
Authority
CO
Colombia
Prior art keywords
chemical compound
sodium salt
hydrated form
crystalline hydrated
phenylpiro
Prior art date
Application number
CO98011404A
Other languages
English (en)
Spanish (es)
Inventor
Cimarosti Zadeo
Paolo Maragni
Original Assignee
Glaxo Wellcome Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Wellcome Spa filed Critical Glaxo Wellcome Spa
Publication of CO4940415A1 publication Critical patent/CO4940415A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Neurology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Neurosurgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Indole Compounds (AREA)
CO98011404A 1997-03-05 1998-03-03 Compuesto quimico CO4940415A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9704498.6A GB9704498D0 (en) 1997-03-05 1997-03-05 Chemical compound

Publications (1)

Publication Number Publication Date
CO4940415A1 true CO4940415A1 (es) 2000-07-24

Family

ID=10808697

Family Applications (1)

Application Number Title Priority Date Filing Date
CO98011404A CO4940415A1 (es) 1997-03-05 1998-03-03 Compuesto quimico

Country Status (29)

Country Link
EP (1) EP0966463A1 (xx)
JP (1) JP2001513796A (xx)
KR (1) KR20000075907A (xx)
CN (1) CN1249750A (xx)
AP (1) AP9901637A0 (xx)
AR (1) AR011178A1 (xx)
AU (1) AU6825198A (xx)
BG (1) BG103779A (xx)
BR (1) BR9808305A (xx)
CA (1) CA2282851A1 (xx)
CO (1) CO4940415A1 (xx)
EA (1) EA199900710A1 (xx)
EE (1) EE9900387A (xx)
GB (1) GB9704498D0 (xx)
HR (1) HRP980114A2 (xx)
HU (1) HUP0002109A2 (xx)
ID (1) ID24207A (xx)
IL (1) IL131489A0 (xx)
IS (1) IS5166A (xx)
NO (1) NO994303L (xx)
NZ (1) NZ337315A (xx)
OA (1) OA11154A (xx)
PE (1) PE51399A1 (xx)
PL (1) PL335652A1 (xx)
SK (1) SK119699A3 (xx)
TR (1) TR199902117T2 (xx)
WO (1) WO1998039327A1 (xx)
YU (1) YU43499A (xx)
ZA (1) ZA981791B (xx)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9704499D0 (en) * 1997-03-05 1997-04-23 Glaxo Wellcome Spa Method of manufacture
GB9825988D0 (en) 1998-11-27 1999-01-20 Pfizer Ltd Indole derivatives
GB9915231D0 (en) 1999-06-29 1999-09-01 Pfizer Ltd Pharmaceutical complex
US9737531B2 (en) 2012-07-12 2017-08-22 Glytech, Llc Composition and method for treatment of depression and psychosis in humans
RU2020100230A (ru) 2017-06-12 2021-07-13 Глитек Ллс. Лечение депрессии антагонистами nmda и антагонистами d2/5-ht2a или селективными антагонистами 5-нт2a

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9321221D0 (en) * 1993-10-14 1993-12-01 Glaxo Spa Heterocyclic compounds

Also Published As

Publication number Publication date
PE51399A1 (es) 1999-06-07
IL131489A0 (en) 2001-01-28
NO994303L (no) 1999-11-03
EA199900710A1 (ru) 2000-04-24
BR9808305A (pt) 2000-05-16
EE9900387A (et) 2000-04-17
ID24207A (id) 2000-07-13
HUP0002109A2 (hu) 2001-04-28
SK119699A3 (en) 2000-05-16
IS5166A (is) 1999-08-27
PL335652A1 (en) 2000-05-08
TR199902117T2 (xx) 2000-03-21
AU6825198A (en) 1998-09-22
OA11154A (en) 2003-04-16
CN1249750A (zh) 2000-04-05
NZ337315A (en) 2001-02-23
BG103779A (en) 2000-06-30
HRP980114A2 (en) 1998-12-31
JP2001513796A (ja) 2001-09-04
KR20000075907A (ko) 2000-12-26
EP0966463A1 (en) 1999-12-29
NO994303D0 (no) 1999-09-03
GB9704498D0 (en) 1997-04-23
AP9901637A0 (en) 1999-09-30
ZA981791B (en) 1999-09-03
CA2282851A1 (en) 1998-09-11
WO1998039327A1 (en) 1998-09-11
AR011178A1 (es) 2000-08-02
YU43499A (sh) 2000-12-28

Similar Documents

Publication Publication Date Title
AR061765A2 (es) Proceso para la preparcion de sal de sodio de pravastatina en una forma cristalina
FI20002767A (fi) Jodoniumsuolat latentteina happodonoreina
PT1177176E (pt) Derivados de acidos triarilicos como ligandos de receptores ppar.
AR043266A2 (es) Forma cristalina de la sal de adicion de acido monometansulfonico de un derivado de n-fenil-2-pirimidinamina
MA25654A1 (fr) Cristallisation selective du sel de sodium de l'acide 3-pyridyl-1-hydroxyethylidene-1,1-bisphosphonique, sous la forme hemipentahydrate au monohydrate.
GT199900199A (es) Composiciones de glisofato acuoso altamente concentrado.
SV1999000068A (es) Jarabe antihistaminico estabilizado
ATE485835T1 (de) Antikörper enthaltende pharmazeutische lösungen
ATE526022T1 (de) Stabilisierte zusammenstellungen die benzimidazole enthalten
NO20034393L (no) Dobbelt matesystem for kjemikalie i fast form
ES2187261B2 (es) Compuestos de eteres y amidas y su preparacion, como agentes anti-diabeticos.
CO4940415A1 (es) Compuesto quimico
PT1122245E (pt) 2-amino-benzoxazinonas para o tratamento de infeccoes virais
FI973586A0 (fi) Tahnamainen puhdistuskoostumus
EA200101150A1 (ru) Раствор прукалоприда для перорального применения
ATE110261T1 (de) Feste orale applikationsformen, die als wirkstoff ifosfamid enthalten.
ES2149354T3 (es) Solucion acuosa, estable de folinato.
DK1239935T3 (da) Antiskummiddel og anvendelsen heraf
BR0107483A (pt) Processo para a preparação de um composto
DE60117620D1 (de) Herstellung von cephalosporin
ES2135889T3 (es) Composiciones herbicidas mixtas.
ES2195752B1 (es) Procedimiento para la preparacion de polimorfos cristalinos de la sal sodica del fosinopril.
AR022849A1 (es) Procedimiento para la obtencion de sales de la 2,2-dioxido-3-isopropil-2,1,3-benzotiadiazin-4-ona
ATE340821T1 (de) Carboxymethylcellulose mit verbesserter löslichkeit im wasser
GT199900142A (es) Procedimiento para preparar sales de trovafloxacina de adicion de acidos.